Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)

INTRODUCTION: Post-marketing surveillance activities (namely pharmacovigilance) are crucial to favor the early detection of unexpected adverse events (AEs) and/or serious adverse reactions (SAEs). Indeed, spontaneous reporting of AEs has been demonstrated to underestimate the number of events in dif...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Palleria, Caterina, Iannone, Luigi, Leporini, Christian, Citraro, Rita, Manti, Antonia, Caminiti, Maurizio, Gigliotti, Pietro, Grembiale, Rosa Daniela, L’Andolina, Massimo, Muccari, Giuseppe, Naturale, Maria Diana, Olivo, Domenico, Pagano Mariano, Giuseppa, Pellegrini, Roberta, Varcasia, Giuseppe, Abdalla, Karim, Russo, Emilio, Ursini, Francesco, De Sarro, Giovambattista
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200211/
https://ncbi.nlm.nih.gov/pubmed/30356301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205134
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы